Publications 2013
239.
Brown CE, Mischak H, Abalat A, Mullen W, Sattar N, McCarthy NS, Hughes AD, Thom S, Mayet J, Stanton A.
PA. 2. Urinary proteomics can be predictive of cardiovascular events
J Hum Hypertens. 2013, 27(10):647.
238.
Berry M, Galinier M, Delmas C, Fournier P, Desmoulin F, Barutaut M, Mischak H, Butler J, Smih F, Rouet P.
New heart failure diagnostic and prognostic biomarkers discovered using capillary electrophoresis coupled to mass spectroscopy
Eur Heart J. 2013, 34(Suppl 1):2821.
237.
Mermelekas G, Makridakis M, Koeck T, Vlahou A.
Redox proteomics: from residue modifications to putative biomarker identification by gel- and LC-MS-based approaches
Expert Rev Proteomics
2013, 10(6):537-49.
236.
Husi H, Sanchez-Niño MD, Delles C, Mullen W, Vlahou A, Ortiz A, Mischak H.
A combinatorial approach of Proteomics and Systems Biology in unravelling the mechanisms of acute kidney injury (AKI): involvement of NMDA receptor GRIN1 in murine AKI
BMC Syst Biol. 2013, 7:110.
235.
Dissard R, Klein J, Caubet C, Breuil B, Siwy J, Hoffman J, Sicard L, Ducassé L, Rascalou S, Payre B, Buléon M, Mullen W, Mischak H, Tack I, Bascands JL, Buffin-Meyer B, Schanstra JP.
Long Term Metabolic Syndrome Induced by a High Fat High Fructose Diet Leads to Minimal Renal Injury in C57BL/6 Mice
PLoS One 2013, 3;8(10):e76703.
234.
Neuhaus J, Schiffer E, Siwy J, Mannello F, Horn LC, Stolzenburg JU.
Proteome-based diagnostic and prognostic biomarkers of prostate cancer
Urologe A. 2013, 52(9):1251-5.
233.
Latosinska A, Frantzi M, Vlahou A, Mischak H.
Clinical applications of capillary electrophoresis coupled to mass spectrometry in biomarker discovery: Focus on Bladder Cancer
Proteomics Clin Appl. 2013, 7(11-12):779-93.
232.
Klein J, Lacroix C, Caubet C, Siwy J, Zürbig P, Dakna M, Muller F, Breuil B, Stalmach A, Mullen W, Mischak H, Bandin F, Monsarrat B, Bascands JL, Decramer S, Schanstra JP.
Fetal Urinary Peptides to Predict Postnatal Outcome of Renal Disease in Fetuses with Posterior Urethral Valves (PUV)
Sci Transl Med. 2013, 5(198):198ra106.
231.
Albalat A, Stalmach A, Bitsika V, Siwy J, Schanstra JP, Petropoulos AD, Vlahou A, Jankowski J, Persson F, Rossing P, Jaskolla TW, Mischak H, Husi H.
Improving peptide relative quantification in MALDI-TOF MS for biomarker assessment
Proteomics 2013, 13(20):2967-75.
230.
Tedesco S, Mullen W, Mischak H, Bradshaw C, Cristobal S.
Shotgun proteomics in blue mussels exposed to benthic trawler-induced sediment resuspension from a polluted fjord
Farm Animal Proteomics 2013, Editors: de Almeida A, Eckersall D, Bencurova E, Dolinska S, Mlynarcik P, Vincova M, Bhide MR, pp.
258–261.
229.
Schönemeier B, Metzger J, Rosendahl J, Plentz R, Wiegand J, Mischak H, Manns MP, Lankisch TO.
Die Proteomanalyse im Urin als nicht-invasive Methode zur Detektion von Pankreaskarzinomen
Zeitschrift für Gastroenterologie
2013, 51(8):K216.
228.
Lankisch TO, Metzger J, Voigtländer T, Schönemeier B, Mischak H, Manns MP.
Kombinierte Gallensaft- und Urin-Proteom-Analyse zur Diagnose eines Cholangiokarzinoms bei Patienten mit unklaren Gallenwegsprozessen
Zeitschrift für Gastroenterologie
2013, 51(8):K169.
227.
Frantzi M, Zoidakis J, Papadopoulos T, Zurbig P, Katafigiotis I, Stravodimos K, Lazaris A, Giannopoulou I, Ploumidis A, Mischak H, Mullen WB, Vlahou A.
IMAC fractionation in combination with LC-MS reveals H2B and NIF-1 peptides as potential bladder cancer biomarkers
J Proteome Res. 2013, 12(9):3969-79. Epub 2013 Aug 21.
226.
Albalat A, Bitsika V, Zurbig P, Siwy J, Mullen W.
High-resolution proteome/peptidome analysis of body fluids by capillary electrophoresis coupled with MS
Methods Mol Biol. 2013, 984:153-65.
225.
Neuhaus J, Schiffer E, Wilcke P, Bauer HW, Leung H, Siwy J, Ulrici W, Paasch U, Horn LC, Stolzenburg J.
Seminal Plasma as a Source of Prostate Cancer Peptide Biomarker Candidates for Detection of Indolent and Advanced Disease
PLoS One 2013, 8(6): e67514.
224.
Klein G, Schanstra JP, Hoffmann J, Mischak H, Siwy J.
Proteomics as a Quality Control Tool of Pharmaceutical Probiotic Bacterial Lysate Products
PLoS One 2013, 8(6):e66682.
223.
Argilés A, Siwy J, Duranton F, Gayrard N, Dakna M, Lundin U, Osaba L, Delles C, Mourad G, Weinberger KM, Mischak H.
CKD273, a New Proteomics Classifier Assessing CKD and Its Prognosis
PLoS One 2013, 8(5):e62837.
222.
Jankowski V, Schulz A, Kretschmer A, Mischak H, Boehringer F, van der Giet M, Janke D, Schuchardt M, Herwig R, Zidek W, Jankowski J.
The enzymatic activity of the VEGFR2 receptor for the biosynthesis of dinucleoside polyphosphates
J Mol Med (Berl). 2013, 91(9):1095-107. Epub 2013 May 1.
221.
Mansor R, Mullen W, Albalat A, Zerefos P, Mischak H, Barrett DC, Biggs A, Eckersall PD.
A peptidomic approach to biomarker discovery for bovine mastitis
J Proteomics 2013, 85:89-98. Epub 2013 Apr 30.
220.
Stalmach A, Albalat A, Mullen W, Mischak H.
Recent advances in capillary electrophoresis coupled to mass spectrometry for clinical proteomic applications
Electrophoresis 2013, 34(11):1452-64. Epub 2013 May 8.
View Abstract Request Reprint
219.
Mischak H, Vlahou A, Ioannidis JP.
Technical aspects and inter-laboratory variability in native peptide profiling: The CE-MS experience
Clin Biochem. 2013, 46(6):432-43. Epub 2012 Oct 4.
218.
Klein J, Eales J, Zürbig P, Vlahou A, Mischak H, Stevens R.
Proteasix: a tool for automated and large-scale prediction of proteases involved in naturally-occurring peptide generation
Proteomics 2013, 13(7):1077-82. Epub 2013 Feb 26.
View
Abstract Request
Reprint
217.
Kistler AD, Serra AL, Siwy J, Poster D, Krauer F, Torres VE, Mrug M, Grantham JJ, Bae KT, Bost JE, Mullen W, Wüthrich RP, Mischak H, Chapman AB.
Urinary proteomic biomarkers for diagnosis and risk stratification of autosomal dominant polycystic kidney disease: a multicentric study
PLoS One. 2013, 8(1):e53016. Epub 2013 Jan 10.
View
Abstract Request
Reprint
216.
Albalat A, Franke J, Gonzalez J, Mischak H, Zürbig P.
Urinary proteomics based on capillary electrophoresis coupled to mass spectrometry in kidney disease
Methods Mol Biol. 2013;919:203-13.
View
Abstract Request
Reprint
215.
Metzger J, Negm AA, Plentz RR, Weismüller TJ, Wedemeyer J, Karlsen TH, Dakna M, Mullen W, Mischak H, Manns MP, Lankisch TO
Urine proteomic analysis differentiates cholangiocarcinoma from primary sclerosing cholangitis and other benign biliary disorders
Gut 2013, 62(1):122-30. Epub 2012 May 12.
214.
Roscioni SS, de Zeeuw D, Hellemons ME, Mischak H, Zürbig P, Bakker SJ, Gansevoort RT, Reinhard H, Persson F, Lajer M, Rossing P, Heerspink HJ.
A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus
Diabetologia 2013, 56(2):259-67. Epub 2012 Oct 20.
213.
Carty DM, Schiffer E, Delles C.
Proteomics in hypertension
J Hum Hypertens. 2013, 27(4):211-6. Epub 2012 Aug 9.
View
Abstract Request
Reprint